Start Low, Go Slow : Dosage matters
So, how low is too low when it comes to blood pressure
Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease
Your journey toward better health and improved quality of life starts with understanding your condition and connecting with experts who can provide the specialized care you deserve
ACHIEVE-1: Topline Results for Safety ACHIEVE-1 is among seven phase III trials being conducted by Eli Lilly across a range of patients with diabetes and obesity
Moreover, GHK-Cu supports hair growth by revitalizing hair follicles, making it beneficial in treating hair thinning (1)